Lergilez 5 Mg 5 mg FC tablets

    Lergilez 5 Mg 5 mg FC tablets

    S1
    PDF Leaflet Revision Date: 29 September 2023


    Clinical Summary

    Quick overview from the medicine insert

    Indication

    Relief of symptoms associated with allergic conditions.

    Dosage (summary)

    Adults: 5 mg once daily; Children 6-12 years: 5 mg once daily.

    Special Populations

    • Elderly
    • Renal impairment

    Pregnancy & Breastfeeding

    Contraindicated in pregnancy and breastfeeding.

    Key Drug Interactions

    • Alcohol
    • CNS depressants
    • Theophylline

    Contraindications

    • Hypersensitivity to levocetirizine
    • Children < 2 years
    • End-stage renal disease < 10 mL/min

    Common side effects

    • Somnolence
    • Headache
    • Dry mouth

    Counselling Points

    • Take with or without food.
    • May cause sedation in some individuals.
    • Avoid alcohol.

    Serious warnings

    • Risk of urinary retention
    • Caution in epilepsy
    Important Disclaimer

    The Lergilez 5 Mg 5 mg FC tablets professional information leaflet below is the property of Austell Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

    Healthcare Professionals Only

    This content is for registered healthcare professionals

    Sign in or create a free account to read the full package insert.

    Free for HPCSA-registered professionals. Powered by Medinsert.

    Successfully Stashed! 💊

    This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

    View My Favourites
    WhatsApp Email LinkedIn